We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Groups Question Why CDER Had No Input Into FDA’s Device Software Guidance
Industry Groups Question Why CDER Had No Input Into FDA’s Device Software Guidance
It's problematic that the FDA’s recently released device software draft guidance lacked input from the Center for Drug Evaluation and Research (CDER), two industry groups said in written comments to the agency.